X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3674) 3674
Publication (353) 353
Book Review (50) 50
Book Chapter (42) 42
Book / eBook (5) 5
Dissertation (5) 5
Conference Proceeding (3) 3
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2186) 2186
index medicus (1560) 1560
humans (1397) 1397
male (1059) 1059
phosphodiesterase inhibitors - pharmacology (1006) 1006
rats (911) 911
phosphodiesterase (731) 731
pharmacology & pharmacy (715) 715
biochemistry & molecular biology (666) 666
mice (558) 558
chemistry, medicinal (547) 547
cyclic amp - metabolism (486) 486
structure-activity relationship (453) 453
female (426) 426
cell biology (373) 373
dose-response relationship, drug (373) 373
3',5'-cyclic-amp phosphodiesterases - antagonists & inhibitors (342) 342
chemistry, organic (333) 333
in vitro techniques (332) 332
neurosciences (329) 329
cells, cultured (325) 325
phosphoric diester hydrolases - metabolism (320) 320
camp (313) 313
enzyme inhibitors - pharmacology (301) 301
expression (288) 288
analysis (278) 278
enzymes (277) 277
nitric oxide (274) 274
cyclic gmp - metabolism (273) 273
proteins (272) 272
rats, sprague-dawley (270) 270
phosphodiesterase inhibitors (268) 268
sildenafil (265) 265
activation (246) 246
inhibitors (239) 239
inhibition (238) 238
phosphodiesterase inhibitors - chemical synthesis (234) 234
signal transduction (234) 234
rats, wistar (228) 228
phosphodiesterase inhibitors - chemistry (227) 227
cyclic amp (226) 226
molecular structure (224) 224
nitric-oxide (218) 218
phosphorylation (218) 218
apoptosis (215) 215
kinetics (212) 212
cgmp (209) 209
physiology (209) 209
article (208) 208
3',5'-cyclic-amp phosphodiesterases - metabolism (204) 204
sildenafil citrate (204) 204
erectile dysfunction (197) 197
in-vitro (195) 195
cells (189) 189
cyclic nucleotide phosphodiesterases, type 4 (188) 188
rolipram (188) 188
1-methyl-3-isobutylxanthine - pharmacology (187) 187
cell line (186) 186
sphingomyelin phosphodiesterase - metabolism (179) 179
phosphodiesterases (177) 177
cyclic-nucleotide phosphodiesterases (175) 175
physiological aspects (175) 175
research (172) 172
disease models, animal (166) 166
kinases (162) 162
phosphodiesterase inhibitors - therapeutic use (161) 161
piperazines - pharmacology (160) 160
inflammation (159) 159
signal transduction - drug effects (159) 159
rodents (156) 156
ceramide (154) 154
research article (153) 153
time factors (148) 148
derivatives (147) 147
models, molecular (145) 145
medicine (144) 144
nitric-oxide synthase (144) 144
cyclic-nucleotide phosphodiesterase (143) 143
gene expression (143) 143
identification (141) 141
multidisciplinary sciences (140) 140
asthma (138) 138
cattle (138) 138
oxidative stress (137) 137
cyclic gmp (136) 136
cell line, tumor (135) 135
cancer (134) 134
drug design (134) 134
guinea pigs (132) 132
cyclic nucleotide phosphodiesterases, type 4 - metabolism (131) 131
rabbits (131) 131
urology & nephrology (131) 131
brain (129) 129
nitric oxide - metabolism (125) 125
calcium - metabolism (124) 124
cyclic-amp (124) 124
health aspects (124) 124
protein binding (123) 123
biophysics (121) 121
chemistry, multidisciplinary (118) 118
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 03/2012, Volume 20, Issue 5, pp. 1644 - 1658
(−)-6-(7-Methoxy-2-trifluoromethylpyrazolo[1,5- ]pyridin-4-yl)-5-methyl-4,5-dihydro-3-(2 )-pyridazinone (KCA-1490) is a dual PDE3/4 inhibitor that exhibits... 
Phosphodiesterase (PDE) | Fused bicyclic heteroaromatics | Dual PDE3/4 inhibitor | Asthma | COPD | CHEMISTRY, MEDICINAL | MANAGEMENT | RECEPTOR ANTAGONISTS | COMBINATION THERAPY | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | INHALED CORTICOSTEROIDS | CHEMISTRY, ORGANIC | OBSTRUCTIVE PULMONARY-DISEASE | SMOOTH-MUSCLE | POSITIVE INOTROPIC AGENTS | CARDIOTONIC AGENTS | Phosphodiesterase 4 Inhibitors - chemistry | Anti-Inflammatory Agents - pharmacology | Phosphodiesterase 3 Inhibitors - chemistry | Phosphodiesterase 3 Inhibitors - pharmacology | Pyridines - chemistry | Bridged Bicyclo Compounds, Heterocyclic - chemistry | Humans | Pyridines - chemical synthesis | Models, Molecular | Bronchodilator Agents - pharmacology | Structure-Activity Relationship | Bronchodilator Agents - chemical synthesis | Phosphodiesterase 4 Inhibitors - pharmacology | Phosphodiesterase 4 Inhibitors - chemical synthesis | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Bronchodilator Agents - chemistry | Phosphodiesterase 3 Inhibitors - chemical synthesis | Anti-Inflammatory Agents - chemistry | Bronchoconstriction - drug effects | Drug Design | Anti-Inflammatory Agents - chemical synthesis | Pyridines - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - chemical synthesis | Anti-inflammatory drugs | Lung diseases, Obstructive
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 09/2011, Volume 21, Issue 18, pp. 5451 - 5456
A structural survey of pyrazolopyridine-pyridazinone phosphodiesterase (PDE) inhibitors was made with a view to optimization of their dual PDE3/4-inhibitory... 
Ibudilast | PDE3 inhibitors | Cyclic 3′,5′-nucleotide phosphodiesterase (PDE) | Respiratory disease | PDE4 inhibitors | Cyclic 3',5'-nucleotide phosphodiesterase (PDE) | Cyclic 3 ',5 '-nucleotide phosphodiesterase (PDE) | CHRONIC HEART-FAILURE | SLOW REACTING SUBSTANCE | CHEMISTRY, MEDICINAL | CHEMISTRY, ORGANIC | IDENTIFICATION | OBSTRUCTIVE PULMONARY-DISEASE | ASTHMA | POSITIVE INOTROPIC AGENTS | HIGHLY POTENT | CARDIOTONIC AGENTS | Phosphodiesterase 3 Inhibitors - chemistry | Phosphodiesterase 3 Inhibitors - pharmacology | Pyrazoles - chemical synthesis | Pyridines - chemistry | Stereoisomerism | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Structure-Activity Relationship | Phosphodiesterase 4 Inhibitors - chemical synthesis | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Bronchodilator Agents - chemistry | Pyrazoles - chemistry | Drug Design | Molecular Structure | Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Drug Evaluation, Preclinical | Pyrazoles - pharmacology | Phosphodiesterase 4 Inhibitors - chemistry | Guinea Pigs | Pyridines - chemical synthesis | Rats | Bronchodilator Agents - pharmacology | Bronchodilator Agents - chemical synthesis | Phosphodiesterase 4 Inhibitors - pharmacology | Phosphodiesterase 3 Inhibitors - chemical synthesis | Animals | Pyridines - pharmacology | Anti-inflammatory drugs | Pyridine
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 01/2013, Volume 23, Issue 1, pp. 375 - 381
(−)-6-(7-Methoxy-2-(trifluoromethyl)pyrazolo[1,5- ]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2 )-one (KCA-1490) exhibits moderate dual PDE3/4-inhibitory... 
Phosphodiesterase (PDE) | Inhaled administration | Dual PDE3/4 inhibitor | Asthma | COPD | MORTALITY | CHRONIC HEART-FAILURE | BRONCHODILATORY ACTIVITY | DESIGN | CHEMISTRY, MEDICINAL | CHEMISTRY, ORGANIC | 4,5-DIHYDRO-6-<4-(1H-IMIDAZOL-1-YL)PHENYL>-3(2H)-PYRIDAZINONES | OBSTRUCTIVE PULMONARY-DISEASE | POSITIVE INOTROPIC AGENTS | CORTICOSTEROIDS | CARDIOTONIC AGENTS | ROFLUMILAST | Cyclic Nucleotide Phosphodiesterases, Type 3 - chemistry | Phosphodiesterase 3 Inhibitors - chemistry | Phosphodiesterase 3 Inhibitors - pharmacology | Pyridines - chemistry | Structure-Activity Relationship | Phosphodiesterase 4 Inhibitors - chemical synthesis | Bronchodilator Agents - chemistry | Drug Design | Bronchoalveolar Lavage Fluid - cytology | Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 4 - chemistry | Phosphodiesterase 4 Inhibitors - chemistry | Anti-Inflammatory Agents - pharmacology | Administration, Inhalation | Rats | Bronchodilator Agents - pharmacology | Bronchodilator Agents - chemical synthesis | Phosphodiesterase 4 Inhibitors - pharmacology | Pyridazines - chemistry | Phosphodiesterase 3 Inhibitors - chemical synthesis | Animals | Anti-Inflammatory Agents - chemistry | Protein Binding | Leukocytes - drug effects | Anti-Inflammatory Agents - chemical synthesis | Anti-inflammatory drugs | Respiratory agents
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 08/2014, Volume 57, Issue 15, pp. 6632 - 6641
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 2011, Volume 46, Issue 10, pp. 4946 - 4956
Journal Article
Journal Article